Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Lescoat

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
Current Opinion in Rheumatology|September 10, 2021
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implicationsAlain Lescoat, Valérie Lecureur, John Varga
Particle and Fibre Toxicology|March 1, 2024
Results from omic approaches in rat or mouse models exposed to inhaled crystalline silica: a systematic reviewLaura Morin, Valérie Lecureur, Alain Lescoat
Current Opinion in Rheumatology|July 11, 2025
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burdenAlain Lescoat, Yen T Chen, Dinesh Khanna
International Journal of Social Determinants of Health and Health Services|January 30, 2025
The Banning of Engineered Stone in Australia: An Evidence-Based and Precautionary PolicyCatherine Cavalin, Alfredo Menéndez-Navarro, Alain Lescoat
British Journal of Haematology|October 10, 2014
Demonstration of the cause of acute renal failure in a case of IgD multiple myelomaAlain Lescoat, Nathalie Rioux-Leclercq, Cécile Vigneau
Expert Review of Clinical Immunology|September 16, 2024
Innovative cell therapies for systemic sclerosis: available evidence and new perspectivesAlain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Seminars in Immunopathology|November 11, 2025
Systemic sclerosis: pathogenic mechanisms and their implications for treatmentAlain Lescoat, Valérie Lecureur, Johann E Gudjonsson, et al.
Journal of Internal Medicine|January 5, 2024
Regarding: Clinical presentation, course, and prognosis of patients with mixed connective tissue diseaseAlexis Dechosal, Erwan Le Tallec, Nicolas Belhomme, et al.
Expert Opinion on Investigational Drugs|April 28, 2021
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicineAlain Lescoat, John Varga, Marco Matucci-Cerinic, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
Current Opinion in Rheumatology|September 10, 2021
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implicationsAlain Lescoat, Valérie Lecureur, John Varga
Particle and Fibre Toxicology|March 1, 2024
Results from omic approaches in rat or mouse models exposed to inhaled crystalline silica: a systematic reviewLaura Morin, Valérie Lecureur, Alain Lescoat
Current Opinion in Rheumatology|July 11, 2025
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burdenAlain Lescoat, Yen T Chen, Dinesh Khanna
International Journal of Social Determinants of Health and Health Services|January 30, 2025
The Banning of Engineered Stone in Australia: An Evidence-Based and Precautionary PolicyCatherine Cavalin, Alfredo Menéndez-Navarro, Alain Lescoat
British Journal of Haematology|October 10, 2014
Demonstration of the cause of acute renal failure in a case of IgD multiple myelomaAlain Lescoat, Nathalie Rioux-Leclercq, Cécile Vigneau
Expert Review of Clinical Immunology|September 16, 2024
Innovative cell therapies for systemic sclerosis: available evidence and new perspectivesAlain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Seminars in Immunopathology|November 11, 2025
Systemic sclerosis: pathogenic mechanisms and their implications for treatmentAlain Lescoat, Valérie Lecureur, Johann E Gudjonsson, et al.
Journal of Internal Medicine|January 5, 2024
Regarding: Clinical presentation, course, and prognosis of patients with mixed connective tissue diseaseAlexis Dechosal, Erwan Le Tallec, Nicolas Belhomme, et al.
Expert Opinion on Investigational Drugs|April 28, 2021
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicineAlain Lescoat, John Varga, Marco Matucci-Cerinic, et al.
Pageof 15